Lisa Peraza Heron Therapeutics, Inc. (HRTX) insider trading activity

HRTX Quotes by TradingView

Lisa Peraza is VP, Chief Accounting Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 55,907 shares of HRTX, which is worth approximately $100,632. The most recent transaction as insider was on Apr 13, 2021, when has been sold 191 shares (Common Stock) at a price of $16.66 per share, resulting in proceeds of $3,182. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.9K
0% 3M change
5.09% 12M change
Total Value Held $100,632

Lisa Peraza Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 13 2021
SELL
Payment of exercise price or tax liability
$3,182 $16.66 p/Share
191 Reduced 1.57%
11,945 Common Stock
Apr 13 2021
BUY
Exercise of conversion of derivative security
-
552 Added 4.35%
12,136 Common Stock
Jan 13 2021
SELL
Payment of exercise price or tax liability
$4,122 $18.16 p/Share
227 Reduced 1.92%
11,584 Common Stock
Jan 13 2021
BUY
Exercise of conversion of derivative security
-
552 Added 4.46%
11,811 Common Stock
LP

Lisa Peraza

VP, Chief Accounting Officer
San Diego, CA

Track Institutional and Insider Activities on HRTX

Follow HERON THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

News

Receive news related to HERON THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HRTX